Point72 Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Point72 Asset Management's BSX Position: Q1 2026 in Review
Point72 Asset Management increased its Boston Scientific (BSX) stake by 51% in Q1 2026, buying an estimated $100M and bringing the position to 3,687,315 shares worth $231M. The position accounts for 0.3% of the portfolio, ranked #41.
Point72 Asset Management first reported a position in BSX in Q3 2014 and has held it in 40 quarters since. The position peaked at $339M in Q3 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Point72 Asset Management held 3,687,315 shares of Boston Scientific worth $231M as of Q1 2026.
- Point72 Asset Management bought 1,252,752 Boston Scientific shares in Q1 2026, an estimated $100M.
- Boston Scientific made up 0.3% of Point72 Asset Management's portfolio in Q1 2026, its #41 holding.
- Point72 Asset Management first reported a position in Boston Scientific in Q3 2014 and has held it in 40 quarters since.
- Point72 Asset Management's Boston Scientific position peaked at $339M in Q3 2023.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.